MARQUETTA ADAMS: Open Payments
NPI 1942778162 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 15 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 4 | $300 |
| Inspire Medical Systems, Inc. | 1 | $143 |
| ABIOMED | 1 | $137 |
| Amgen Inc. | 1 | $132 |
| GENZYME CORPORATION | 1 | $125 |
| Shionogi Inc | 1 | $124 |
| Boston Scientific Corporation | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| ViiV Healthcare Company | 1 | $115 |
| Sandoz Inc. | 1 | $112 |
Products named: QUTENZA, INSPIRE, REPATHA, WATCHMAN FLX, FLUMIST QUADRIVALENT, APRETUDE, DUPIXENT, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
